BTK-001

N/A

Report date: 2023/07/17 11:34:26

Base Information

Drug NameBTK-001
Drug Alias NameBTK-001
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Lentiviral vector
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsPrimary Immunodeficiency Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIsrael
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNoga Therapeutics Ltd
China Registration ClassN/A

Develop Information

Active CompaniesNoga Therapeutics Ltd
Inactive CompaniesN/A
Active IndicationsPrimary Immunodeficiency Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A